| Dr Monica Anne Lucht, MD | |
|
2525 Ne 139th St, Vancouver, WA 98686-2719 | |
| (360) 397-3820 | |
| (360) 604-1758 |
| Full Name | Dr Monica Anne Lucht |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2525 Ne 139th St, Vancouver, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134338742 | NPI | - | NPPES |
| 8546749 | Medicaid | WA | |
| 0250802 | Other | WA | L & I |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD60095721 (Washington) | Primary |
| Entity Name | The Vancouver Clinic Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992759427 PECOS PAC ID: 3173436490 Enrollment ID: O20031111000793 |
News Archive
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
Researchers at the Swedish medical university Karolinska Institutet have discovered a mechanism that controls the brain's ability to create lasting memories. In experiments on genetically manipulated mice, they were able to switch on and off the animals' ability to form lasting memories by adding a substance to their drinking water. The findings, which are published in the scientific journal PNAS, are of potential significance to the future treatment of Alzheimer's and stroke.
The Tennessee Biotechnology Association and its Graduate Alliance are jointly hosting an afternoon of biotech, business, and law on December 7th, 2009. This event will be held at Belmont University with a reception at 5pm sponsored by i3 Research.
A qualitative study of 22 cancer patients shows how acceptance is key to living as well as possible, although it requires time and is a process with ups and downs. Led by the University of Navarre, this research emphasizes the importance of focusing on life rather than on the disease.
In a new study, published recently on the bioRxiv preprint server, researchers isolated a nanobody that potently neutralizes SARS-CoV-2, including the B.1.351 variant, and cross-neutralizes SARS-CoV. They demonstrated the therapeutic potential of the nanobody in a human ACE2 (angiotensin-converting enzyme) transgenic mouse model.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Monica Anne Lucht, MD 700 Ne 87th Ave, Vancouver, WA 98664-1913 Ph: (360) 397-3820 | Dr Monica Anne Lucht, MD 2525 Ne 139th St, Vancouver, WA 98686-2719 Ph: (360) 397-3820 |
News Archive
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
Researchers at the Swedish medical university Karolinska Institutet have discovered a mechanism that controls the brain's ability to create lasting memories. In experiments on genetically manipulated mice, they were able to switch on and off the animals' ability to form lasting memories by adding a substance to their drinking water. The findings, which are published in the scientific journal PNAS, are of potential significance to the future treatment of Alzheimer's and stroke.
The Tennessee Biotechnology Association and its Graduate Alliance are jointly hosting an afternoon of biotech, business, and law on December 7th, 2009. This event will be held at Belmont University with a reception at 5pm sponsored by i3 Research.
A qualitative study of 22 cancer patients shows how acceptance is key to living as well as possible, although it requires time and is a process with ups and downs. Led by the University of Navarre, this research emphasizes the importance of focusing on life rather than on the disease.
In a new study, published recently on the bioRxiv preprint server, researchers isolated a nanobody that potently neutralizes SARS-CoV-2, including the B.1.351 variant, and cross-neutralizes SARS-CoV. They demonstrated the therapeutic potential of the nanobody in a human ACE2 (angiotensin-converting enzyme) transgenic mouse model.
› Verified 1 days ago
Aidan H Derenne, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 505 Ne 87th Ave, Ste 120, Vancouver, WA 98664 Phone: 360-892-1635 Fax: 360-892-3146 | |
Charles E Fuchs, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 505 Ne 87th Ave, Ste 120, Vancouver, WA 98664 Phone: 360-892-1635 Fax: 360-892-3146 | |
Laurie Metzger, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-397-1500 Fax: 360-397-1328 | |
Jing Jing Wang, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-882-2778 Fax: 360-604-1758 | |
Veronica S Erhart, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 6100 Ne Fourth Plain Blvd, Vancouver, WA 98661 Phone: 360-891-7300 | |
Katherine Elizabeth Holland, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 505 Ne 87th Ave, Suite 120, Vancouver, WA 98664 Phone: 360-892-1635 Fax: 360-892-3146 | |
Jennifer L Soden, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 505 Ne 87th Ave, Ste 120, Vancouver, WA 98664 Phone: 360-892-1635 Fax: 360-892-3146 |